PCV6 Cost-Effectiveness and Budget Impact Analysis of Rivaroxaban in the Prevention of Thromboembolic Events in Patients Performing Hip and Knee Arthroplasty in Comparison With Enoxaparin Under the Brazilian Private Health Care System Persp ...
Nov 1, 2011, 00:00
10.1016/j.jval.2011.08.1578
https://www.valueinhealthjournal.com/article/S1098-3015(11)03140-8/fulltext
Title :
PCV6 Cost-Effectiveness and Budget Impact Analysis of Rivaroxaban in the Prevention of Thromboembolic Events in Patients Performing Hip and Knee Arthroplasty in Comparison With Enoxaparin Under the Brazilian Private Health Care System Persp ...
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)03140-8&doi=10.1016/j.jval.2011.08.1578
First page :
A545
Section Title :
Cardiovascular Disorders
Open access? :
No
Section Order :
1518